Crestline Management’s PepGen PEPG Stock Holding History

Crestline Management’s Portfolio PEPG Stock Details PEPG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-31,230	Closed	-$498K	–	542
2024 Q2	$498K	Sell	31,230 -3,770	-11%	-$54K	0.04%	158
2024 Q1	$515K	Buy	+35,000	New	+$413K	0.05%	156

Other funds holding PEPG

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Crestline Management's PEPG Position: Q3 2024 in Review

Crestline Management sold out of PepGen (PEPG) in Q3 2024, closing a stake of 31,230 shares — an estimated $498K sold.

Crestline Management first reported a position in PEPG in Q1 2024 and held it in 2 quarters. The position peaked at $515K in Q1 2024. 62 funds tracked by Wall St. Rank hold PEPG as of Q3 2024.

Crestline Management reported no remaining PepGen position as of Q3 2024 after selling out during the quarter.
Crestline Management sold 31,230 PepGen shares in Q3 2024, an estimated $498K.
Crestline Management first reported a position in PepGen in Q1 2024 and held it in 2 quarters.
Crestline Management's PepGen position peaked at $515K in Q1 2024.
62 funds tracked by Wall St. Rank held PepGen as of Q3 2024.

Based on Crestline Management's 13F filing for Q3 2024, filed 13 Nov 2024.